Class of 2024
For leading-edge findings involving colorectal cancer pathogenesis in patients with DNA mismatch repair defects, groundbreaking genetic cohort studies defining colon cancer disparity outcomes, and for uncovering that colon cancer patients of African American descent often present with elevated levels of the EMAST biomarker commonly associated with poor prognosis.
*Full-length biography pending